trial · primary record
Inavolisib
Breast Cancer
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 80 |
| Primary completion | 2030-02-26 |
| Primary endpoint | Percentage of Participants With Confirmed Objective Response (cORR) |
| Registry ID | NCT07405801 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:42.432Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07405801
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Inavolisib · approval
- Inavolisib · compound